EP4363616A4 - DETECTION OF LOSS OF HETEROZYGOSY OF HUMAN LEUKOCY ANTIGEN - Google Patents

DETECTION OF LOSS OF HETEROZYGOSY OF HUMAN LEUKOCY ANTIGEN

Info

Publication number
EP4363616A4
EP4363616A4 EP21948675.0A EP21948675A EP4363616A4 EP 4363616 A4 EP4363616 A4 EP 4363616A4 EP 21948675 A EP21948675 A EP 21948675A EP 4363616 A4 EP4363616 A4 EP 4363616A4
Authority
EP
European Patent Office
Prior art keywords
heterozygosy
leukocy
antigen
loss
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP21948675.0A
Other languages
German (de)
French (fr)
Other versions
EP4363616A1 (en
Inventor
Ariane Lozac'hmeur
Jason PERERA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tempus AI Inc
Original Assignee
Tempus AI Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US17/304,940 external-priority patent/US11475978B2/en
Application filed by Tempus AI Inc filed Critical Tempus AI Inc
Publication of EP4363616A1 publication Critical patent/EP4363616A1/en
Publication of EP4363616A4 publication Critical patent/EP4363616A4/en
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/10—Ploidy or copy number detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10—Sequence alignment; Homology search
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Data Mining & Analysis (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Evolutionary Computation (AREA)
  • Microbiology (AREA)
  • Software Systems (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioethics (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Artificial Intelligence (AREA)
  • Databases & Information Systems (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP21948675.0A 2021-06-28 2021-07-16 DETECTION OF LOSS OF HETEROZYGOSY OF HUMAN LEUKOCY ANTIGEN Pending EP4363616A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17/304,940 US11475978B2 (en) 2019-02-12 2021-06-28 Detection of human leukocyte antigen loss of heterozygosity
PCT/US2021/042039 WO2023277932A1 (en) 2021-06-28 2021-07-16 Detection of human leukocyte antigen loss of heterozygosity

Publications (2)

Publication Number Publication Date
EP4363616A1 EP4363616A1 (en) 2024-05-08
EP4363616A4 true EP4363616A4 (en) 2025-04-30

Family

ID=84690558

Family Applications (1)

Application Number Title Priority Date Filing Date
EP21948675.0A Pending EP4363616A4 (en) 2021-06-28 2021-07-16 DETECTION OF LOSS OF HETEROZYGOSY OF HUMAN LEUKOCY ANTIGEN

Country Status (4)

Country Link
EP (1) EP4363616A4 (en)
AU (1) AU2021454223A1 (en)
CA (1) CA3219608A1 (en)
WO (1) WO2023277932A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116612808B (en) * 2023-05-05 2025-11-25 成都爱诺言医学检验实验室有限公司 A method for detecting HIV-1 drug resistance genes based on NGS technology
CN117409868B (en) * 2023-12-14 2024-02-20 成都大熊猫繁育研究基地 Panda genetic map drawing method and system

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3130203A1 (en) * 2019-02-12 2020-08-20 Tempus Labs, Inc. Detection of human leukocyte antigen loss of heterozygosity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014116729A2 (en) * 2013-01-22 2014-07-31 The Board Of Trustees Of The Leland Stanford Junior University Haplotying of hla loci with ultra-deep shotgun sequencing
EP3651791A1 (en) * 2017-07-14 2020-05-20 The Francis Crick Institute Limited Analysis of hla alleles in tumours and the uses thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3130203A1 (en) * 2019-02-12 2020-08-20 Tempus Labs, Inc. Detection of human leukocyte antigen loss of heterozygosity

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
NICHOLAS MCGRANAHAN ET AL: "Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution", CELL, vol. 171, no. 6, 1 November 2017 (2017-11-01), Amsterdam NL, pages 1259 - 1271.e11, XP055547263, ISSN: 0092-8674, DOI: 10.1016/j.cell.2017.10.001 *
See also references of WO2023277932A1 *
WATKINS THOMAS B K ET AL: "Pervasive chromosomal instability and karyotype order in tumour evolution", NATURE,, vol. 587, no. 7832, 2 September 2020 (2020-09-02), pages 126 - 132, XP037295102, DOI: 10.1038/S41586-020-2698-6 *

Also Published As

Publication number Publication date
EP4363616A1 (en) 2024-05-08
CA3219608A1 (en) 2023-01-08
WO2023277932A1 (en) 2023-01-05
AU2021454223A1 (en) 2024-01-18

Similar Documents

Publication Publication Date Title
EP3924503A4 (en) DETECTION OF LOSS OF HETEROZYGOTIA OF HUMAN LEUCOCYTE ANTIGEN
EP3953332A4 (en) TRICYCLIC DEGRADING AGENTS OF IKAROS AND AIOLOS
EP4095148A4 (en) EXATECAN ANTI-TOO-2-ANALOG ANTIBODY CONJUGATE AND ITS MEDICAL USE
EP3876786A4 (en) ORAL HYGIENE INSTRUMENT
EP3831853A4 (en) PROTEIN RECOGNIZING THE DRUG FRACTION OF AN ANTIBODY-DRUG CONJUGATE
EP1506286A4 (en) HUMAN ANTI-HUMAN NEUTRALIZING ANTIBODIES
MA54615A (en) MONOCLONAL ANTIBODY AGAINST HUMAN INTERLEUKIN-4 ALPHA RECEPTOR AND ITS USE
EP4121556A4 (en) ANALYTE DETECTION
EP4138913A4 (en) RAPID DETECTION OF NEUTRALISING ANTIBODIES AGAINST A VIRUS AT THE POINT OF CARE
EP3873941A4 (en) HUMAN ANTI-PD-1 ANTIBODIES AND METHODS OF USE THEREOF
EP3808900A4 (en) SOLAR INDUCTION LAMP AND INDUCTION SYSTEM USING THE SAME
EP3673100A4 (en) DYNAMIC LIGHT CHAIN BANKS OF HUMAN ANTIBODIES
EP4363616A4 (en) DETECTION OF LOSS OF HETEROZYGOSY OF HUMAN LEUKOCY ANTIGEN
EP3960688A4 (en) CRANE AND CRANE INSPECTION SYSTEM
IL309025B1 (en) Deaminase-based RNA sensors
EP4029878A4 (en) HUMAN MONOCLONAL ANTIBODY TARGETING YKL-40
EP4005306A4 (en) FULL DUPLEX INTERVAL CONFIGURATION
EP3916375A4 (en) BIOLOGICAL SAMPLE DETECTION DEVICE
EP4257617A4 (en) CD70-TARGETING ANTIGEN-BINDING PROTEIN AND ITS USE
EP1680666A4 (en) ANTI-THERAPEUTIC HUMAN ANTIBODY DETECTION
EP3721381A4 (en) ANTI-USURPATION FACE ID DETECTION
IL290817A (en) Methods for producing recombinant human arginase 1 and uses thereof
EP4261224A4 (en) CD73 ANTIGEN-BINDING PROTEIN AND ITS APPLICATION
EP4367145A4 (en) NEW ANTIBODY SEQUENCES FOR DIAGNOSTIC AND THERAPY PURPOSES
EP3833691A4 (en) HUMAN ANTI-PD-L1 ANTIBODIES

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20231107

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
P01 Opt-out of the competence of the unified patent court (upc) registered

Free format text: CASE NUMBER: APP_49016/2024

Effective date: 20240828

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: C12Q0001688600

Ipc: G16B0020200000

A4 Supplementary search report drawn up and despatched

Effective date: 20250328

RIC1 Information provided on ipc code assigned before grant

Ipc: C12Q 1/6886 20180101ALI20250324BHEP

Ipc: G16B 40/20 20190101ALI20250324BHEP

Ipc: G16B 30/10 20190101ALI20250324BHEP

Ipc: G16B 20/10 20190101ALI20250324BHEP

Ipc: G16B 20/20 20190101AFI20250324BHEP